Thailand cannabis 2026: the reset from open market to prescription-only
Executive summary
Thailand's cannabis market — Asia's first legal one, worth around THB 42.8 bn (USD 1.2 bn) at its 2025 peak — has been pulled back under medical control. A June 2025 controlled-herb notification ended open retail: only 15.5% of shops renewed their 2025 licences (1,339 of 8,636), operating outlets are set to fall from an 11.1k peak toward ~5.5k by 2027, and just 217 farms hold GACP export-ready status. The plant stays legal, but value is migrating from storefront volume to prescription, certification and export.
This report covers the macro reset (the June 2025 controlled-herb notification, decoded), market sizing from the green-rush peak through the reset, licensing dynamics and the renewal collapse, medical demand and the prescription rails being rebuilt, the operator landscape barbell of certified integrators versus a closing tail, the six fronts where the profit pool relocates, and scenarios to 2030 hinging on the pending Cannabis-Hemp Act.
A dedicated value-migration section maps where margin moves as the market re-regulates — toward GACP-certified cultivation, prescription-linked clinics and pharmacies, certified medical supply, and the export pivot to regulated overseas markets — with a forecast that turns on whether the Cannabis-Hemp Act codifies the medical regime or reopens recreational access.
Report details
- Published
- 2026-07-14
- Pages
- 16
- Format
- Code
- TH-HLT-XPL-D26-02
- Market
- Thailand
- Industry
- Cannabis
- Year
- 2026
Table of contents · 9 sections
- 01 Executive summary
- 02 Market sizing
- 03 The regulatory reset
- 04 Licensing dynamics
- 05 Medical demand
- 06 Operator landscape
- 07 Value migration
- 08 Forecast and outlook
- 09 Methodology & sources
The full report is available to subscribers and buyers. The executive summary above is free to read.